Can Magnetic Resonance Imaging Predict Pathologic Findings for Endometrioid Endometrial Cancer?

Autor:	Dickson Michelson EL; Oncology, Aurora West Allis Medical Center, West Allis, WI., Kram JJF; Aurora UW Medical Group, Aurora Health Care, Milwaukee, WI.; Center for Urban Population Health, Milwaukee, WI., Heslin K; Aurora UW Medical Group, Aurora Health Care, Milwaukee, WI.; Center for Urban Population Health, Milwaukee, WI.; Aurora Research Institute, Aurora Health Care, Milwaukee, WI., Baugh D; Radiology, Aurora St. Luke's Medical Center, Milwaukee, WI., Bamra V; Radiology, Aurora St. Luke's Medical Center, Milwaukee, WI., Hu J; Radiology, Aurora St. Luke's Medical Center, Milwaukee, WI., Shukla A; Pathology, Aurora St. Luke's Medical Center, Aurora Health Care, Milwaukee, WI., Kamelle SA; Oncology, Aurora St. Luke's Medical Center, Milwaukee, WI.
Jazyk:	angličtina
Zdroj:	Journal of patient-centered research and reviews [J Patient Cent Res Rev] 2020 Apr 27; Vol. 7 (2), pp. 206-212. Date of Electronic Publication: 2020 Apr 27 (Print Publication: 2020).
DOI:	10.17294/2330-0698.1720
Abstrakt:	This pilot study aimed to assess the feasibility of precisely measuring tumor diameter and myometrial invasion in patients with endometrioid endometrial cancer (EEC) using preoperative contrast-enhanced magnetic resonance imaging (MRI). Adult patients with confirmed diagnosis of complex hyperplasia with atypia or EEC were included. Three radiologists separately measured tumor diameter and myometrial invasion. Basic descriptive statistics were used to describe patient characteristics and to compare radiology- and pathology-measured tumor diameter and myometrial invasion. Using the pathology results for tumor diameter as the gold standard for comparison, at least 1 radiologist was able to predict largest tumor diameter within 5 mm for 41.7% of patients. Similarly, based on pathology results for myometrial invasion, at least 1 radiologist was able to predict myometrial invasion within 5% for 50% of patients. All radiologists were able to predict superficial (<50%) or deep (≥50%) myometrial invasion for 75% of patients, with greater sensitivity, specificity, and accuracy for deep myometrial invasion. Given variation among radiologic measurements, it is difficult to recommend preoperative MRI as a basis for measuring tumor diameter and myometrial invasion. Even so, the ability to predict superficial versus deep myometrial invasion may benefit patients with EEC for whom surgery is not a viable option or for those seeking fertility-sparing treatment options. Competing Interests: Conflicts of Interest None. (© 2020 Aurora Health Care, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu